1.Indravudh, P. P., A. T. Choko, and E. L. Corbett, Scaling up HIV self-testing in sub-Saharan Africa: a review of technology, policy and evidence. Current opinion in infectious diseases, 2018. 31(1): p. 14.
2.Wondimeneh, Y., et al., HIV and Malaria Infections and Associated Risk Factors Among Febrile Illness Patients in Northwest Ethiopia. Türkiye Parazitolojii Dergisi, 2018. 42(3): p. 180.
3.Mitku, A. A., et al., Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. African health sciences, 2016. 16(2): p. 588–595.
4.Emerson, P.M., et al., Integrating an NTD with one of “the big three”: combined malaria and trachoma survey in Amhara Region of Ethiopia. PLoS neglected tropical diseases, 2008. 2(3).
5.Tadesse, S., F. Enqueselassie, and S. H. Gebreyesus, Estimating the spatial risk of tuberculosis distribution in Gurage zone, southern Ethiopia: a geostatistical kriging approach. BMC public health, 2018. 18(1): p. 783.
6.Workneh, M. H., G. A. Bjune, and S. A. Yimer, Prevalence and associated factors of diabetes mellitus among tuberculosis patients in South-Eastern Amhara Region, Ethiopia: a cross sectional study. PLoS One, 2016. 11(1).
7.Beyene, M. B. and H. B. Beyene, Predictors of late HIV diagnosis among adult people living with HIV/AIDS who undertake an initial CD4 T cell evaluation, northern Ethiopia: a case-control study. PloS one, 2015. 10(10): p. e0140004.
8.Mariz, C.d.A., et al., Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity. Cadernos de saude publica, 2011. 27(10): p. 1997–2008.
9.Macallan, D.C., Nutrition and immune function in human immunodeficiency virus infection. Proceedings of the Nutrition society, 1999. 58(3): p. 743–748.
10.Langebeek, N., et al., Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC medicine, 2014. 12(1): p. 142.
11.Amberbir, A., et al., Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC public health, 2008. 8(1): p. 265.
12.Alvarez-Uria, G., et al., Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low-and middle-income countries. Interdisciplinary perspectives on infectious diseases, 2013. 2013.
13.Schwimmer, J. B., T. M. Burwinkle, and J. W. Varni, Health-related quality of life of severely obese children and adolescents. Jama, 2003. 289(14): p. 1813–1819.
14.Do, N. T., et al., Psychosocial factors affecting medication adherence among HIV–1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS research and human retroviruses, 2010. 26(6): p. 685–691.
15.Belle, D., Poverty and women’s mental health. American psychologist, 1990. 45(3): p. 385.
16.Alok, R., et al., Problem-focused coping and self-efficacy as correlates of quality of life and severity of fibromyalgia in primary fibromyalgia patients. JCR: Journal of Clinical Rheumatology, 2014. 20(6): p. 314–316.
17.Guerrero, M., J. Rialp, and D. Urbano, The impact of desirability and feasibility on entrepreneurial intentions: A structural equation model. International Entrepreneurship and Management Journal, 2008. 4(1): p. 35–50.
18.Guerrero, J. M., et al., Hierarchical control of droop-controlled AC and DC microgrids—A general approach toward standardization. IEEE Transactions on industrial electronics, 2010. 58(1): p. 158–172.
19.Seyoum, A. and Z. Temesgen, Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region). AIDS research and therapy, 2017. 14(1): p. 14.
20.De Wit, L., et al., Motor and functional recovery after stroke a comparison of 4 European rehabilitation centers. Stroke, 2007. 38(7): p. 2101–2107.
21.Bayou, T., et al., Factors determinant for change of initial antiretroviral treatment regimen among patients on ART follow-up clinic of Mekelle Hospital, Mekelle, Ethiopia. Int J Basic Clin Pharmacol, 2014. 3(1): p. 44–9.
22.Ezeamama, A. E., et al., Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV–tuberculosis co-infected patients on combination antiretroviral therapy. International Journal of Infectious Diseases, 2015. 35: p. 73–79.
23.Ye, R.-H., et al., Studies on the determinants and changes related to the natural CD4 (+) T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture, Yunnan province. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2011. 32(9): p. 882–887.
24.Rao, D., et al., A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS and Behavior, 2012. 16(3): p. 711–716.
25.Kipp, A.M., et al., Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members. BMC Public Health, 2011. 11(1): p. 675.
26.Maqutu, D., et al., Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS and Behavior, 2011. 15(7): p. 1465–1474.
27.Florence, E., et al., Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV medicine, 2003. 4(3): p. 255–262.
28.Seyoum, A. and T. Zewotir, Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in north–West Ethiopia (Amhara region). AIDS research and therapy, 2016. 13(1): p. 36.
29.Tegegne, A. S. and T. Zewotir, Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models. BMC infectious diseases, 2018. 18(1): p. 197.
30.Ebonyi, A. O., et al., Factors associated with a low CD4 count among HIV–1 infected patients at enrolment into HAART in Jos, Nigeria. British Journal of Medicine and Medical Research, 2014. 4(13): p. 2536.
31.Montarroyos, U. R., et al., Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis. PloS one, 2014. 9(2): p. e84276.
32.Smith, C. J., et al., Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. Journal of Infectious Diseases, 2004. 190(10): p. 1860–1868.
33.Adams, M. and A. Luguterah, Longitudinal analysis of change in CD4+ cell counts of HIV–1 patients on antiretroviral therapy (ART) in the Builsa district hospital. European Scientific Journal, 2013. 9(33).
34.Asfaw, A., et al., CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study. PloS one, 2015. 10(3): p. e0122583.